Results 141 to 150 of about 10,096 (214)

Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study. [PDF]

open access: yesInt J Gynecol Cancer
Thaker PH   +8 more
europepmc   +1 more source

Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer. [PDF]

open access: yesFuture Oncol
Westin SN   +29 more
europepmc   +1 more source

[Cancer prevention recommendations: Update 2024]. [PDF]

open access: yesAten Primaria
Bartolomé-Moreno C   +7 more
europepmc   +1 more source

Integrative taxonomy uncovers <i>Clinostomum chaacci</i> and an unidentified congeneric metacercaria infecting <i>Hoplosternum littorale</i> (Siluriformes: Callichthyidae) in the Peruvian Amazon Basin. [PDF]

open access: yesFood Waterborne Parasitol
Chero JD   +9 more
europepmc   +1 more source

[Endocrine-Metabolic Evaluation of female infertility in public health: initial results in the interior of the country] [PDF]

open access: yesRev Fac Cien Med Univ Nac Cordoba
Tarletta M   +10 more
europepmc   +1 more source

[Gemcitabine-induced digital necrosis in a patient with cervical squamous cell carcinoma: case report and literature review]. [PDF]

open access: yesRev Colomb Obstet Ginecol
Guarín-Rivera S   +4 more
europepmc   +1 more source

Preoperative neutrophil/lymphocyte ratio as prognostic factor in epithelial ovarian cancer [PDF]

open access: yesRev Colomb Obstet Ginecol
Vázquez Rojo J   +2 more
europepmc   +1 more source

Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer [PDF]

open access: yesRev Colomb Obstet Ginecol
Pierre ME   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy